Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Hein

Showing results (61-70 of 173) with videos related to

Pageof 18
Sort By:
Breast Cancer Research : BCR|January 25, 2025
Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markersLothar Häberle, Ramona Erber, Paul Gass, et al.
HLA|August 5, 2024
Validation and functional follow-up of cervical cancer risk variants at the HLA locusRieke Eisenblätter, Finja Seifert, Peter Schürmann, et al.
Breast Cancer Research : BCR|April 12, 2012
Characterizing mammographic images by using generic texture featuresLothar Häberle, Florian Wagner, Peter A Fasching, et al.
Geburtshilfe Und Frauenheilkunde|July 31, 2018
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among PhysiciansPaul Gass, Michael Untch, Volkmar Müller, et al.
Breast Cancer Research and Treatment|May 5, 2018
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patientsMarius Wunderle, Paul Gass, Lothar Häberle, et al.
Oncotarget|November 5, 2017
Clinical validation of genetic variants associated with <i>in vitro</i> chemotherapy-related lymphoblastoid cell toxicityPeter A Fasching, Lothar Häberle, Brigitte Rack, et al.
Breast Cancer Research and Treatment|March 13, 2013
Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasisChristian R Loehberg, Katrin Almstedt, Sebastian M Jud, et al.
Cell|April 8, 2017
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous RetrovirusesKatherine B Chiappinelli, Pamela L Strissel, Alexis Desrichard, et al.
Science Advances|March 27, 2021
Odontoblast TRPC5 channels signal cold pain in teethLaura Bernal, Pamela Sotelo-Hitschfeld, Christine König, et al.
Cell|April 12, 2016
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous RetrovirusesKatherine B Chiappinelli, Pamela L Strissel, Alexis Desrichard, et al.
Pageof 18

Showing results (61-70 of 173) with videos related to

Sort By:
Pageof 18
Breast Cancer Research : BCR|January 25, 2025
Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markersLothar Häberle, Ramona Erber, Paul Gass, et al.
HLA|August 5, 2024
Validation and functional follow-up of cervical cancer risk variants at the HLA locusRieke Eisenblätter, Finja Seifert, Peter Schürmann, et al.
Breast Cancer Research : BCR|April 12, 2012
Characterizing mammographic images by using generic texture featuresLothar Häberle, Florian Wagner, Peter A Fasching, et al.
Geburtshilfe Und Frauenheilkunde|July 31, 2018
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among PhysiciansPaul Gass, Michael Untch, Volkmar Müller, et al.
Breast Cancer Research and Treatment|May 5, 2018
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patientsMarius Wunderle, Paul Gass, Lothar Häberle, et al.
Oncotarget|November 5, 2017
Clinical validation of genetic variants associated with <i>in vitro</i> chemotherapy-related lymphoblastoid cell toxicityPeter A Fasching, Lothar Häberle, Brigitte Rack, et al.
Breast Cancer Research and Treatment|March 13, 2013
Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasisChristian R Loehberg, Katrin Almstedt, Sebastian M Jud, et al.
Cell|April 8, 2017
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous RetrovirusesKatherine B Chiappinelli, Pamela L Strissel, Alexis Desrichard, et al.
Science Advances|March 27, 2021
Odontoblast TRPC5 channels signal cold pain in teethLaura Bernal, Pamela Sotelo-Hitschfeld, Christine König, et al.
Cell|April 12, 2016
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous RetrovirusesKatherine B Chiappinelli, Pamela L Strissel, Alexis Desrichard, et al.
Pageof 18